AI Imaging specialist closes $66m funding round

Aidoc, a provider of artificial intelligence (AI) solutions for medical imaging, has announced a $66 million investment, bringing its total funding to $140 million. 

This Series C round, led by General Catalyst, follows a surge in demand for Aidoc’s AI-driven solutions, including the largest clinical deployment of AI in healthcare through its partnership with Radiology Partners.

Aidoc co-founder and CEO Elad Walach, said: “This investment comes after significant milestones; expanding our product lines, doubling our FDA clearances and quadrupling our customer base. We are experiencing a huge expansion, which is also a direct result of C-level executives adopting an AI strategy and integrating our platform as a must-have solution across clinical pathways. It is truly rewarding – and a great responsibility – to be the trusted partner of the most innovative health systems and physician practices across the globe.”

A pioneer in healthcare AI, Aidoc's FDA-cleared solutions analyse medical images for critical conditions and trigger actionable alerts directly in the imaging workflow supporting medical specialists in reducing turnaround time and improving quality of care. With the new funding, Aidoc will expand its platform – a cross-specialty AI platform for medical imaging – taking AI solutions to the enterprise-grade level, while allowing medical specialists to leverage AI for better outcomes.

In research conducted by leading health systems, Aidoc’s solutions have shown a correlation with reduction of length of stay in the ED and Inpatient settings. Aidoc’s deep learning technology is always-on, running behind the scenes and allowing medical specialists to focus on better diagnosis.